Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122167677 | 12216767 | 7 | F | 201603 | 20160907 | 20160329 | 20160921 | PER | US-PFIZER INC-2016158547 | PFIZER | 69.00 | YR | M | Y | 106.00000 | KG | 20160921 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122167677 | 12216767 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (2 WEEKS ON/1 WEEK OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 122167677 | 12216767 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, 1X/DAY | Y | 595BA | 21938 | 50 | MG | CAPSULE, HARD | QD | |||||
| 122167677 | 12216767 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Y | 21938 | CAPSULE, HARD | ||||||||||
| 122167677 | 12216767 | 4 | C | PAROXETINE. | PAROXETINE | 1 | UNK | 0 | |||||||||||
| 122167677 | 12216767 | 5 | C | ALLOPURINOL. | ALLOPURINOL | 1 | UNK | 0 | |||||||||||
| 122167677 | 12216767 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | 0 | |||||||||||
| 122167677 | 12216767 | 7 | C | VALIUM | DIAZEPAM | 1 | UNK | 0 | |||||||||||
| 122167677 | 12216767 | 8 | C | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | UNK, AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122167677 | 12216767 | 1 | Metastatic renal cell carcinoma |
| 122167677 | 12216767 | 2 | Tumour necrosis |
| 122167677 | 12216767 | 3 | Renal cancer |
| 122167677 | 12216767 | 8 | Dental care |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122167677 | 12216767 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122167677 | 12216767 | Abdominal discomfort | |
| 122167677 | 12216767 | Abdominal pain upper | |
| 122167677 | 12216767 | Blood pressure increased | |
| 122167677 | 12216767 | Constipation | |
| 122167677 | 12216767 | Cough | |
| 122167677 | 12216767 | Diarrhoea | |
| 122167677 | 12216767 | Dry skin | |
| 122167677 | 12216767 | Faeces discoloured | |
| 122167677 | 12216767 | Fatigue | |
| 122167677 | 12216767 | Feeling abnormal | |
| 122167677 | 12216767 | Flatulence | |
| 122167677 | 12216767 | Headache | |
| 122167677 | 12216767 | Productive cough | |
| 122167677 | 12216767 | Pruritus | |
| 122167677 | 12216767 | Respiratory tract congestion | |
| 122167677 | 12216767 | Skin discolouration | |
| 122167677 | 12216767 | Skin exfoliation | |
| 122167677 | 12216767 | Sunburn | |
| 122167677 | 12216767 | Tongue discomfort |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122167677 | 12216767 | 1 | 20160304 | 0 | ||
| 122167677 | 12216767 | 2 | 201603 | 201608 | 0 |